Does the combined antenatal use of corticosteroids and antibiotics increase late-onset neonatal sepsis in the very low birth weight infant?
Article Abstract:
Giving pregnant women at risk of premature delivery corticosteroids and antibiotics does not increase the risk of bacterial infection in the newborn baby. These drugs are used to prevent respiratory distress syndrome and group B streptococcal infections in newborn babies. However, corticosteroids can suppress the immune system and antibiotics can kill protective bacteria.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: A randomized controlled pilot study
Article Abstract:
A study is conducted to determine whether intravenous magnesium sulfate (MgSO4) followed by oral nifidepine tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks' gestation reduces neonatal hospital stay. Results reveal that tocolysis after 32 weeks gestation does not reduce neonatal hospital stay.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. Caffeine therapy for apnea of prematurity
- Abstracts: The Alabama preterm birth study: Corticosteroids and neonatal outcomes in 23- and 32-week newborns with various markers of intrauterine infection
- Abstracts: Swallowing, urine flow, and amniotic fluid volume responses to prolonged hypoxia in the ovine fetus. Erythrocyte and erythropoietin responses to hemorrhage in the immature and near term ovine fetus
- Abstracts: The fetoplacental pressor effects of low-dose acetylsalicylic acid and angiotensin II in the ex vivo cotyledon model
- Abstracts: The immunologic profile of infants born after maternal immunoglobulin treatment and intrauterine platelet transfusions for fetal/neonatal alloimmune thrombocytopenia